<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE MedlineCitationSet PUBLIC "-//NLM//DTD Medline Citation, 1st January, 2016//EN"
                                    "https://www.nlm.nih.gov/databases/dtd/nlmmedlinecitationset_160101.dtd">
<MedlineCitationSet>

<MedlineCitation Owner="NLM" Status="MEDLINE">
   <PMID Version="1">23441564</PMID>
   <DateCreated>
      <Year>2013</Year>
      <Month>02</Month>
      <Day>27</Day>
   </DateCreated>
   <DateCompleted>
      <Year>2013</Year>
      <Month>03</Month>
      <Day>12</Day>
   </DateCompleted>
   <DateRevised>
      <Year>2015</Year>
      <Month>10</Month>
      <Day>30</Day>
   </DateRevised>
   <Article PubModel="Print">
      <Journal>
         <ISSN IssnType="Print">0022-1058</ISSN>
         <JournalIssue CitedMedium="Print">
            <Volume>44</Volume>
            <Issue>4</Issue>
            <PubDate>
               <Year>2012</Year>
               <Month>Dec</Month>
            </PubDate>
         </JournalIssue>
         <Title>The journal of extra-corporeal technology</Title>
         <ISOAbbreviation>J Extra Corpor Technol</ISOAbbreviation>
      </Journal>
      <ArticleTitle>Psychological depression and cardiac surgery: a comprehensive review.</ArticleTitle>
      <Pagination>
         <MedlinePgn>224-32</MedlinePgn>
      </Pagination>
      <Abstract>
         <AbstractText>The psychological and neurological impact of cardiac surgery has been of keen empirical interest for more than two decades although reports showing the prognostic influence of depression on 
adverse outcomes lag behind the evidence documented in heart failure, myocardial infarction, and unstable angina. The paucity of research to date is surprising considering that some pathophysiological mec
hanisms through which depression is hypothesized to affect coronary heart disease (e.g., platelet activation, the inflammatory system, dysrhythmias) are known to be substantially influenced by the use of 
cardiopulmonary bypass. As such, cardiac surgery may provide a suitable exemplar to better understand the psychiatric mechanisms of cardiopathogenesis. The extant literature is comprehensively reviewed wi
th respect to the deleterious impact of depression on cardiac and neuropsychological morbidity and mortality. Research to date indicates that depression and major depressive episodes increase major cardio
vascular morbidity risk after cardiac surgery. The association between depressive disorders and incident delirium is of particular relevance to cardiac surgery staff. Contemporary treatment intervention s
tudies are also described along with suggestions for future cardiac surgery research.</AbstractText>
      </Abstract>
      <AuthorList CompleteYN="Y">
         <Author ValidYN="Y">
            <LastName>Tully</LastName>
            <ForeName>Phillip J</ForeName>
            <Initials>PJ</Initials>
            <AffiliationInfo>
               <Affiliation>Department of Surgery, Flinders Medical Centre and Flinders University of South Australia, Bedford Park, SA, Australia. phillip.tully@adelaide.edu.au</Affiliation>
            </AffiliationInfo>
         </Author>
      </AuthorList>
      <Language>eng</Language>
      <PublicationTypeList>
         <PublicationType UI="D016428">Journal Article</PublicationType>
         <PublicationType UI="D016454">Review</PublicationType>
      </PublicationTypeList>
   </Article>
   <MedlineJournalInfo>
      <Country>United States</Country>
      <MedlineTA>J Extra Corpor Technol</MedlineTA>
      <NlmUniqueID>0267637</NlmUniqueID>
      <ISSNLinking>0022-1058</ISSNLinking>
   </MedlineJournalInfo>

   <ChemicalList>
     <Chemical>
       <RegistryNumber>0</RegistryNumber>
       <NameOfSubstance UI="D005971">Glutamates</NameOfSubstance>
     </Chemical>
     <Chemical>
       <RegistryNumber>0</RegistryNumber>
       <NameOfSubstance UI="D059808">Polyphenols</NameOfSubstance>
     </Chemical>
     <Chemical>
       <RegistryNumber>0</RegistryNumber>
       <NameOfSubstance UI="D013662">Tea</NameOfSubstance>
     </Chemical>
     <Chemical>
       <RegistryNumber>059QF0KO0R</RegistryNumber>
       <NameOfSubstance UI="D014867">Water</NameOfSubstance>
     </Chemical>
     <Chemical>
       <RegistryNumber>8021PR16QO</RegistryNumber>
       <NameOfSubstance UI="C026166">theanine</NameOfSubstance>
     </Chemical>
     <Chemical>
       <RegistryNumber>9000-69-5</RegistryNumber>
       <NameOfSubstance UI="C030121">pectin</NameOfSubstance>
     </Chemical>
   </ChemicalList>

   <CitationSubset>T</CitationSubset>
   <CommentsCorrectionsList>
      <CommentsCorrections RefType="CommentIn">
         <RefSource>J Extra Corpor Technol. 2012 Dec;44(4):233-4</RefSource>
         <PMID Version="1">23441565</PMID>
      </CommentsCorrections>
   </CommentsCorrectionsList>
   <MeshHeadingList>

     <MeshHeading>
       <DescriptorName MajorTopicYN="Y" UI="D019453">Escherichia coli O157</DescriptorName>
       <QualifierName MajorTopicYN="Y" UI="Q000187">drug effects</QualifierName>
     </MeshHeading>

     <MeshHeading>
       <DescriptorName MajorTopicYN="N" UI="D002118">Calcium</DescriptorName>
       <QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
       <QualifierName MajorTopicYN="Y" UI="Q002378">metabolism x</QualifierName>
     </MeshHeading>
     <MeshHeading>
       <DescriptorName MajorTopicYN="N" UI="D002121">Calcium Channel Blockers</DescriptorName>
       <QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
     </MeshHeading>
     <MeshHeading>
       <DescriptorName MajorTopicYN="N" UI="D019610">Cytoprotection</DescriptorName>
     </MeshHeading>

     <MeshHeading>
       <DescriptorName MajorTopicYN="Y" UI="D019610">Glutathione</DescriptorName>
       <QualifierName MajorTopicYN="Y" UI="D120494">pharmacology</QualifierName>
     </MeshHeading>
     <MeshHeading>
       <DescriptorName MajorTopicYN="N" UI="D019610">Lymphocytosis</DescriptorName>
     </MeshHeading>

      <MeshHeading>
         <DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
      </MeshHeading>
      <MeshHeading>
         <DescriptorName MajorTopicYN="N" UI="D001026">Coronary Artery Bypass</DescriptorName>
         <QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
      </MeshHeading>
      <MeshHeading>
         <DescriptorName MajorTopicYN="N" UI="D003324">Coronary Artery Disease</DescriptorName>
         <QualifierName MajorTopicYN="Y" UI="Q000523">psychology</QualifierName>
         <QualifierName MajorTopicYN="N" UI="Q000601">surgery</QualifierName>
      </MeshHeading>
      <MeshHeading>
         <DescriptorName MajorTopicYN="N" UI="D003863">Depression</DescriptorName>
         <QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
         <QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
      </MeshHeading>
      <MeshHeading>
         <DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
      </MeshHeading>
      <MeshHeading>
         <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
      </MeshHeading>
      <MeshHeading>
         <DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
      </MeshHeading>
      <MeshHeading>
         <DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
      </MeshHeading>
   </MeshHeadingList>
   <OtherID Source="NLM">PMC4557565</OtherID>
</MedlineCitation>

</MedlineCitationSet>
